Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: AST-301(pNGVL3-hICD)|DRUG: rhuGM-CSF|DRUG: Placebo|DRUG: Pembrolizumab|DRUG: Capecitabine
Sponsor: Aston Sci. Inc.